thiophenes has been researched along with gne 477 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Berry, M; Castanedo, G; Chang, C; Chuckowree, I; Dotson, J; Folkes, A; Gunzner, J; Heffron, TP; Lesnick, JD; Lewis, C; Mathieu, S; Nonomiya, J; Olivero, A; Pang, J; Peterson, D; Salphati, L; Sampath, D; Sideris, S; Sutherlin, DP; Tsui, V; Wan, NC; Wang, S; Wong, S; Zhu, BY | 1 |
Chu, IM; Csiszar, K; Flanders, K; Green, JE; Hoenerhoff, M; Luger, D; Michalowski, AM; Oshima, A; Sato, M; Szauter, KM | 1 |
Huang, H; Huang, WP; Ruan, JW; Ye, X; Zhang, F; Zhang, Y | 1 |
3 other study(ies) available for thiophenes and gne 477
Article | Year |
---|---|
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor.
Topics: Animals; Dogs; Enzyme Inhibitors; Female; Intracellular Signaling Peptides and Proteins; Mice; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Rats; Thiophenes; TOR Serine-Threonine Kinases | 2010 |
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Neoplasms, Basal Cell; Neoplasms, Hormone-Dependent; Prognosis; Protein-Lysine 6-Oxidase; Pyrimidines; Thiophenes | 2012 |
PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Cell Culture Techniques; Cell Cycle; Cell Proliferation; Humans; Kidney Neoplasms; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; Thiophenes; TOR Serine-Threonine Kinases | 2020 |